Since 2010, the US uninsured rate has dropped from 17% to 11% of the population.1 Some of the new episode- and populationbased payment models are achieving savings,2 and some categories of healthcare utilization have declined.3 However, medical inflation still rises faster than GDP growth. There is little transparency into pricing, and, in many regions, the price dispersion for similar services exceeds 100%. All too frequently, the correlation between cost and quality is weak. Regulatory constraints often inhibit much-needed innovations. The health status of the population remains below that of most other peer countries.